AMZN · AMAZON COM INC
10-Q filed 2026-04-30 period 2026-03-31
85 Strong
confidence high · source filing on SEC.gov ↗
- AWS and OpenAI expanded their multi-year commitment and commercial arrangement by $100.0 billion over 8.0 years, focusing on AWS chips.
- Amazon invested $15.0 billion in OpenAI's Series C Preferred Stock in Q1 2026, with an additional commitment to purchase $35.0 billion.
- Trailing twelve-month free cash flow decreased significantly to $1.2 billion from $25.9 billion in the prior year due to a surge in capital expenditures to $147.3 billion.
Filing Health Score pillars
Profitability 25%
92
Revenue grew 17% year-over-year to $181.5 billion in Q1 2026, while operating income expanded 30% to $23.9 billion, demonstrating strong operating leverage as operating expenses grew slower at 15% (Item 2, Results of Operations).
Balance sheet 20%
85
Cash and marketable securities of $143.1 billion exceed long-term debt of $119.1 billion, which increased by $53.4 billion in Q1 2026, while interest coverage remains extremely strong at nearly 30x (Item 1, Consolidated Balance Sheets & Note 5).
Cash generation 20%
65
Operating cash flow rose to $26.0 billion in Q1 2026, but trailing twelve-month free cash flow plummeted to $1.2 billion from $25.9 billion due to massive capital expenditures of $147.3 billion, reflecting high capex intensity for technology infrastructure (Item 2, Liquidity and Capital Resources).
Risk flags 20%
88
The company is clean of going-concern or restatement issues, but faces substantial strategic commitments, including a $100 billion expanded contract with OpenAI and a $50 billion total equity commitment to OpenAI's Series C Preferred Stock (Item 1, Note 1 - Unearned Revenue & Note 4).
Mgmt signal 15%
95
Management signals strong momentum with AWS sales accelerating to 28% growth in Q1 2026 and robust Q2 2026 guidance projecting net sales growth of 16% to 19% and operating income up to $24.0 billion (Item 2, Results of Operations & Guidance).
Key metrics (Three Months Ended March 31, 2026)
revenue: $181,519 million
cash and equivalents: $101,816 million
total debt: $119,074 million
shares outstanding: 10,754 million
net income: $30,255 million
period: Three Months Ended March 31, 2026
operating cash flow: $26,032 million
Gemma triage notes (pre-analysis, second opinion)
None for this filing.Automated research summaries derived from SEC filings. Not investment advice.